FIELD: medicine.
SUBSTANCE: Betaloc, a selective beta-1 adrenergic blocking agent is administered intravenously intermittently in a dose of 0.05-0.1 mg/kg at 1 mg/min. Then 9-11 min after the Betaloc administration is completed, atropine is administered in a dose of 0.04 mg/kg of body weight for 1-2 min. A heart rate is determined 4-6 min after the atropine administration.
EFFECT: more accurate diagnosis of cardiac conduction system diseases by using the selective beta-1 adrenergic blocking agent in the developed doses and dosing regimen.
1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF SICK SINUS NODE SYNDROME | 2002 |
|
RU2220718C1 |
| PHARMACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF CHRONIC DISORDERS OF VEGETATIVE REGULATION OF HEART RHYTHM AND METHOD OF PREVENTION AND TREATMENT BY MEANS OF PHARMACEUTICAL COMBINATION | 2012 |
|
RU2493836C1 |
| METHOD FOR TREATMENT OF CARDIAC RHYTHM DISORDER | 1991 |
|
RU2008903C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF ARTERIAL HYPERTENSION | 1992 |
|
RU2064775C1 |
| METHOD OF EFFECTIVE DOSE SELECTION OF BETA-ADRENERGIC BLOCKING AGENTS IN CARDIOMYOPATHIES IN CHILDREN | 2019 |
|
RU2719909C1 |
| METHOD FOR CHOOSING ANTIARRHYTHMIC THERAPY FOR ATRIOVENTRICULAR TACHYCARDIA | 0 |
|
SU1806741A1 |
| METHOD OF TREATING PATIENTS WITH BRONCHIAL ASTHMA | 2008 |
|
RU2383345C1 |
| METHOD FOR TREATING THE PATIENTS POSSESSING SINUS NODE ASTHENIA | 1993 |
|
RU2110297C1 |
| DIAGNOSTIC METHOD OF HEART DISEASES IN INFECTIOUS DISEASES IN CHILDREN AND ADOLESCENTS | 2018 |
|
RU2680975C1 |
| METHOD FOR LIFE-HARMFUL HEART RATE DISORDERS DEVELOPMENT RISK PREDICTION FOR CHILDREN AND ADOLESCENTS | 2016 |
|
RU2623486C1 |
